More importantly, we found that in HepG2 cells none of ERs was pro-proliferative, as they are in breast, endometrial and ovarian cancer cells; instead, all selective agonists of ER-α, ER-β and GPER stimulated cell apoptosis. The gene discussed is ESR2; the disease is ovarian cancer.